References

bekhterev

Обозрение психиатрии и медицинской психологии имени В.М.Бехтерева

V.M. BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY

2313-70532713-055X

V. M. BEKHTEREV NATIONAL RESEARCH MEDICAL CENTER FOR PSYCHIATRY AND NEUROLOGY OF THE RUSSIAN FEDERATION MINISTRY OF HEALTH

bekhterev-27

Research Article

НАУЧНЫЕ ОБЗОРЫ

SCIENTIFIC REVIEW

Расстройства биполярного спектра при эпилепсии

Bipolar affective disorders in epilepsy

Мазо

Галина Элевна

Mazo

G. E.

galina-mazo@yandex.ru

Липатова

Людмила Валентиновна

Lipatova

L. V.

epilepsy-net@yandex.ru

Жуков

Никита Эдуардович

Zhukov

N. E.

doc@0x3.ru

ФГБУ «Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М. Бехтерева» МЗ РФ; СПбГУRussian FederationФГБУ «Санкт-Петербургский научно-исследовательский психоневрологический институт им. В.М. Бехтерева» МЗ РФRussian Federation

2016

19072018

033040

2018

Мазо Г.Э., Липатова Л.В., Жуков Н.Э.

Mazo G.E., Lipatova L.V., Zhukov N.E.

Данная работа распространяется под лицензией Creative Commons Attribution 4.0.

This work is licensed under a Creative Commons Attribution 4.0 License.

https://www.bekhterevreview.com/jour/article/view/27

Взаимоотношения между расстройствами биполярного спектра и эпилепсией имеют очевидную коморбидность, схожие теоретические основы патогенеза и общие терапевтические подходы. При обоих заболеваниях отмечается высокий риск суицида, без лечения частота эпизодов биполярных аффективных расстройств (БАР) увеличивается, а светлые промежутки становятся короче, прогрессирование заболевания становится похожим на таковое у эпилепсии. Рассматриваются общие патофизиологические механизмы формирования эпилепсии и БАР и принципы лечения аффективных расстройств биполярного спектра у больных эпилепсией (БЭ).

The relationship between bipolar affective disorders (BAD) and epilepsy have an obvious comorbidity, similar theoretical bases of pathogenesis and treatment approaches. In both diseases, there is a high risk of suicide without treatment, the frequency of episodes of BAD increases, and the lucid intervals become shorter, the progression of the disease is similar to one as for epilepsy. Discusses general pathophysiological mechanisms of epilepsy and BAD and treatment of affective disorders of the bipolar spectrum in patients with epilepsy.

расстройства биполярного спектраэпилепсиядепрессиянормотимикиbipolar affective disordersepilepsydepressionmood stabilizers

References1

Воробьева О.В. Фармакотерапия эпилепсии, ассоциированной с депрессией. -Эффективная фармакотерапия. - 2013. - Т. 32. - С. 38-44.

Калинин В.В. Аффективные и тревожные расстройства у больных эпилепсией: вопросы феноменологии и адекватной терапии. - Ж. Вестник эпилептологии. - 2008. - №1. - С. 13-17.

Киссин М. Я. Клиническая эпилептология. - М. Я. Киссин. - М.: ГЭОТАР-Медиа, 2011. - 256 с.

Abraham G., Owen J. Topiramate can cause lithium toxicity. - J. Clin. Psychopharm. - 2004. - Vol. 24. - P. 565-567.

Alper K., Schwartz K.A., Kolts R.L., Khan A. Seizure incidence in psychopharmacological clinical trial: an analysis of Food and Drug Administration (FDA) summary basis of approval reports. - Biol. Psychiatry. - 2007. - Vol. 62. - P. 345-354.

Amman B., Grunze H. Neurochemical underpinnings in bipolar disorder and epilepsy.-Epilepsia. - 2005. - Vol. 46(4). - P. 26-30.

Angst J., Sellaro R. Historical perspectives and natural history of bipolar disorder. - Biol. Psychiatry. - 2000. - Vol. 48(6). - P. 445-457.

Azorin J.M., Kaladjian A. An update on the treatment of bipolar depression. - Expert Opin. Pharmacother. - 2009. - Vol. 10(2). - P. 161 172.

Barry J.J., Ettinger A.B., Fried P., Gilliam F.G., Harden C.L., Hermann B., Kanner A.M., Caplan R., Plioplys S., Salpekar J., Dunn D., Austin J., Jones J. Advisory Group of the Epilepsy Foundation as part of its Mood Disorder. Consensus statement: the evaluation and treatment of people with epilepsy and affective disorders. - Epilepsy Behav. - 2008. - Vol. 13(1). - P. 21-29.

Bauer M., Beaulieu S., Dunner D.L., Lafer B., Kupka R. Rapid cycling bipolar disorder - diagnostic concepts. - Bipolar Disord. - 2008. -Vol. 10(1 Pt 2). - P. 153-162.

Blumer D., Montouris G., Davies K. The interictal dysphoric disorder: recognition, pathogenesis, and treatment of the major psychiatric disorder of epilepsy. - Epilepsy Behav. - 2004. - Vol.5. - P. 826-840.4.

Brent D.A. Overrepresentation of epileptics in a consecutive series of suicide attempters seen at a children’s hospital, 1978-1983. - J Am Acad Child Psychiatry. - 1986. - Vol. 25. - P. 242-6.

Ceron-Litvoc D, Soares BG, Geddes J, Litvoc J, de Lima MS. Comparsion of carbamazepine and lithium in treatment of bipolar disorder: a systematic review of RCTs. - Hum. Psychopharmacol. - 2009. - Vol. 24(1). - P. 19-28.

Charles C.L., Stoesz L., Tollefson G. Zonisamide-induced mania. - Psychosom. - 1990. - Vol. 31(2). - P. 214-217.

Chen C., Veronese L., Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. - 2000. - Br. J. Clin. Pharmacol. - Vol. 50. - P. 193-195.

Clinkers R., Smolders I., Meurs A., Ebinger G., Michoutte Y. Anticonvulsant action of hippocampal dopamine and serotonin is independently mediated by D and 5-HT receptors. - J. Neurochem. - Vol. 89(4). P. 834-843.

Dailey J.W., Naritoku D.K. Antidepressants and seizures: clinical anecdotes overshadow neuroscience. - Biochem. Pharmacol. - 1996. - Vol. 52. - P. 1323-1329.

Dubovsky S.L., Thomas M., Hiazi A., Murphy J. Intracellular calcium signaling in peripheral cells of patients with bipolar affective disorder. - Eur. Arch. Psychiatry Clin. Neurosci. - 1994. - Vol. 243(5).-P. 229-234.

Erwin C.V., Gerber C.J., Morrison S.D., James J.F. Lithium carbonate and convulsive disorders. - Arch. Gen. Psychiatry. -1973. - Vol. 28. - P. 646-648.

Ettinger A.B., Reed M.L., Goldberg J.F., Hirschfeld R.M. Prevalence of bipolar symptoms in epilepsy vs other chronic health disorders. - Neurology. - 2005. - Vol. 65.- P. 535-540.

Ettinger A.B. Psychotropic effects of antiepileptic drugs. - Neurology. - 2006. - Vol. 67(11). P. 1916-1925.

Favale E., Audenino D., Cocito L., Albano C. The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis. - Seizure. - 2003. - Vol. 12. - P. 316-318.

Fountoulakis K.N., Vieta E. Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. - Int. J. Neuropsychopharm. -2008. - Vol. 11(7). - P. 999-1029.

Freeman M.P., Stool A.L. Mood stabilizer combinations: a review of safety and efficacy. - Am. J. Psychiatry. -1998. - Vol. 155. - P. 12-21.

Gao K., Kemp D.E., Ganocy S.J., Gajwani P., Xia G., Calabrese J.R. Antipsychotic-induced extrapyramidal side effects in bipolar disorder and schizophrenia: a systematic review. - J. Clin. Psychopharm. - 2008. - Vol. 28(2). - P. 203-209.

Gillian F.G., Barry J.J., Hermann B.P., Meador K.J., Vahle V., Kanner A.M. Rapid detection of major depression in epilepsy: a multicenter study. - Lancet Neurol. - 2006. - Vol. 5(5). - P. 399-405.

Goddard G.V., McIntyre D.C., Leech C.K. A permanent change in brain function resulting from daily electrical stimulation. - Exp. Neurol. 1969.- Vol. 25(3). - P. 295-330.

Goodwin Gm. Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. - J. Psychopharmacol. 2003. - Vol. 17(2). - P. 149-173.

Grunze H., Kasper S., Goodwin G., Bowden Ch., Baldwin D., Licht R., Vieta E., Moller H.J. World Federation of Societies of Biological Psychiatry Task Force on Treatment Guidelines for Bipolar Disorders (WFSBP). PartI: treatment of bipolar depression. - World J. Biol. Psychiatry. - 2002. - Vol. 3(3). - P. 115-124.

Grunze H., Kasper S., Goodwin G., Bowden C., Moller H.J. WFSBP Task Force on Treatment guidelines for bipolar disorders, part III: maintenance treatment. - World J. Biol. Psychiatry. - 2004. - Vol. 5(3). - P. 120-135.

Guidotti A., Auta J., Davis J.M., Di-Giorgi-Gerevini V., Dwivedi Y., Grayson D.R., Impagnatiello F., Pandey G., Pesold C., Sharma R., Uzunov D., Costa E. Decrease in reelin and glutamic acid decarboxylase 67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. - Arch. Gen. Psychiatry. - 2000.- Vol. 57(11). - P. 1061-1069.

Haddad P.M., Das A., Ashfaq M., Wieck A. A review of valproate in psychiatric practice. Expert Opin. - Drug Metab. Toxicol. - 2009. - Vol. 5(5). - P. 539-551.

Harris E.C., Barraclough B.: Suicide as an outcome for mental disorders. A meta-analysis. - Br J Psychiatry. -1997. - Vol. 170. - P. 205-228.

Hensiek A., Trimble M.R. Relevance of new psychotropic drugs for the neurologist. - J. Neurol. Neurosurg. Psychiatry. - 2002. - Vol. 72. P. 281-285.

Hill R.R., Stagno S.J., Tesar G.E. Secondary mania associated with the use of felbamate. -Psychosomatics. -1995. - Vol. 36(4). - P. 404-406.

Jobe P.C., Browning R.S. The serotonergic and noradrenergic effects of antidepressant drugs are anticonvulsant, not proconvulsant. - Epilepsy Behav. - 2005. - Vol.7. - P. 602-619.

Jus A., Villeneuve A., Gautier J., Pires A., Cote J.M., Jus K., Villeneuve R., Perron D. Influence of lithium carbonate on patients with temporal epilepsy. - Can. Psychiatr. Assoc.J. - 1973. - Vol. 18. - P. 77-78.

Kanner A.M., Kozak A.M., Frey M. The use of sertraline in patientswith epilepsy: is it safe? - Epilepsy Behav. - 2000. - Vol.1. - P. 100-5.

Kanner A.M., Balabanov A. Depression and epilepsy: how closely related are they? - Neurology. - 2002. - Vol.58 (8 Suppl. 5). - P. 227-239.

Kerr M.P., Mensah S., Besag F., Toffol B., Ettinger A., Kanemoto K., Kanner A., Kemp S., Krishnamoorthy E., Curt LaFrance Jr W., Mula M., Schmitz B., Tebartz van Elst L., Trollor J., Wilson S.J. International consensus clinical practice statements for the treatment of neuropsychiatric conditions associated with epilepsy. - Epilepsia. -2011. - Vol. 52(11). P. 2133-2138.

Klein J.P., Jean-Baptiste M., Thompson J.L., Bowers M.B. Jr. A case of hypomania following vagus nerve stimulation for refractory epilepsy. - J. Clin. Psychiatry. - 2003.- Vol. 64(4).-P. 485.

Koch-Stoecker S. Antipsychotic drugs and epilepsy: indications and treatment guidelines. - Epilepsia. - 2002. - Vol. 43(Suppl. 2). - P. 19-24.

Kramlinger K.G., Post R.M. Addition of lithium carbonate to carbamazepine: haematological and thyroid effects. - Am. J. Psychiatry. - 1990. - Vol. 147. -P. 615-620.

Kugoh T., Watanabe M., Obayashi K., Fujioka K., Hosokawa K. Two cases with epilepsy who manifested manic-depressive symptoms under barbiturates treatment. - J. Psychiatry Neurol. - 1991. - Vol. 45(2). - P. 437-438.

Kupka R., Post R. Kindlings as a model for affective disorders. - In: Seizures, Affective Disorders and Anticonvulsant Drugs. Trimble M, Schmitz B (Eds). Clarius Press, Guifold, UK (2002).

Kwan P., Sandler J.W. The natural history of epilepsy: an epidemiological review. - J. Neurol. Psychiatry. -2004. - Vol. 75(10). - P. 1376-1381.

Lewis A. Melancholia: a historical review. - J. Mental Sci. -1934. -Vol. 80. -P. 1-42.

Maes M., Verkerk R., Vandoolaeghe E., Van Hunsel F., Neels H., Wauters A., Demedts P., Scharpe S. Serotonin-immune interactions in major depression: lower serum tryptophan as a marker of an immune-inflamatory response. - Eur. Arch. Psychiatry Clin. Neurosci. -1997. - Vol. 247(3). P. 154-161.

Maj M., Pirozzi R., Magliano L., Bartoli L. Long-term outcome of liyhium prophylaxis in bipolar disorder: a 5-year prospective study of 402 patients at a lithium clinic. - Am. J. Psychiatry. - 1998. -Vol. 155(1). P. 30-35.

Marangell L.B., Bauer M.S., Dennehy E.B., Wisniewski S.R., Allen M.H., Miklowitz D.J., Oquendo M.A., Frank E., Perlis R.H., Martinez J.M., Fagiolini A., Otto M.W., Chessick C.A., Zboyan H.A., Miyahara S., Sachs G., Thase M.E.: Prospective predictors of suicide and suicide attempts in 1,556 patients with bipolar disorders followed for up to 2 years. - Bipolar Disord.- 2006. - Vol. 8.- P. 566575.

Mazza M., Di Nicola M., Della Marca G., Janiri L., Bria P., Mazza S. Bipolar Disorder and Epilepsy: A Bidirectional Relation? Neurobiological Underpinnings, Current Hypotheses, and Future Research Directions. - Neuroscientist. - 2007. - Vol.13. - P. 392.

Monaco F., Mula M. Phenytoin and other hydantoines. Clinical efficacy and use in psychiatric disorders. - In: Antiepileptic Drugs (5th edition). Levy R.H., Mattson R.H., Meldrum B.S., Perucca E. (Eds). Lippincott, Williams & Wilkins, Philadelphia, PA, USA. - 2002. - P. 600-604.

Morimoto K., Sato H., Yamamoto Y., Watanabe T., Suwaki H. Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy. - Epilepsia. -1997. - Vol. 38(9). - P. 966-974.

Mula M., Ester A., Monaco M., Monaco F. Epilepsy and bipolar disorders. - Expert Rev. Neurother. 2010. - Vol. 10(1). - P. 13-23.

Mula M., Jauch R., Cavanna A., Collimedaglia L., Barbagli D., Gaus V., Kretz R., Viana M., Tota G., Israel H., Reuter U., Martus P., Cantello R., Monacj F., Schmitz B. Clinical and psychopathological definition of the interictal dysphoric disorder of epilepsy. - Epilepsia. -2008. - Vol. 49(6). P. 650-656.

Mula M., Monaco F. Antiepileptic drug-induced maina in patients with epilepsy: what do we know? - Epilepsy Behav. - 2006. - Vol. 9(2) - P. 265-267.

Mula M., Sander J.W. Negative effects of antiepileptic drugs on mood in patients with epilepsy. - Drug Saf - 2007. - Vol. 30(7). - P. 555-567.

Mula M., Schmitz B., Jauch R., Cavanna A., Cantello R., Monaco F., Trimble M.R. On the prevalence of bipolar disorder in epilepsy. - Epilepsy Behav. - 2008. - Vol. 13. - P. 658-661.

Nock M.K., Hwang I., Sampson N.A., Kessler R.C. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. - Molecular Psychiatry-2010. - Vol.15. - P. 868-876.

Noe K.H., Locke D.E. C., Sirven J.I. Treatment of Depression in Patients with Epilepsy. - Current Treatment Options in Neurology. - 2011. - Vol.13. - P. 371-379.

Patten S.B., Klein G.M., Lussier C., Sawa R. Organic mania induced by phenytoin: a case report. - Can. J. Psychiatry. -1989. - Vol. 34(8). - P. 827-828.

Petty F. Plasma concentrations of GABA and mood disorders: a blood test for manic depressive disease? - Clin. Chem. - 1994. - Vol. 40(0). - P. 296-302.

Post R.M., Speer A.M., Hough C.J., Xing G. Neurobiology of bipolar illness: implifications for future study and therapeutics. - Ann. Clin. Psychiatry. - 2003. -Vol. 15(2). - P.85-94.

Post R.M., Uhde T.W., Putnam F.W., Ballenger J.C., Berretini W.H. Kindling and carbamazepine in affective illness. - J. Nerv. Ment. Dis. - 1982. -Vol. 170(12). - P. 717-731.

Post R.M., Weiss S.R. A speculative model of affective illness cyclicity based on patterns of drug tolerance observed in amygdala-kindled seizures. - Mol. Neurobiol. -1996. - Vol. 13(1). - P. 33-60.

Quiske A., Helmstaedter C., Lux S., Elger C.E. Depression in patients with temporal lobe epilepsy is related to mesial temporal sclerosis. - Epilepsy Res. - 2000. - Vol. 39(2). - P. 121-125.

Reiss A.I., O’Donell D.J. Carbamazepine-induced mania in two children: case report. - J. Clin. Psychiatry. -1984. - Vol. 45(6). - P. 272-274.

Sastre-Garau P., Thomas P., Beaussart M., Goudemand M. Subsequent manic onset caused by association of vigabatrin-clomipramine. -Encephale. - 1993. -Vol. 4. - P. 51-52.

Schlatter F.J., Soutullo C.A., Cervera-Enguix S. First break mania associated with topiramate treatment. - J. Clin. Psychopharm. - 2001. - Vol. 21(4). - P. 464-466.

Scmitz B. Antidepressant drugs: indications and treatment guidelines for use in epilepsy. - Epileps ia. - 2002. - Vol. 43(Suppl. 2). - P. 13-18.

Short C., Cooke L. Hypomania induced by gabapentin. - Br. J. Psychiatry. -1995. - Vol. 166(5). - P. 679-680.

Spekmann E.J., Straub H., Kohling R. Contribution of calcium ions to the generation of epileptic activity and antiepileptic calcium antagoniam. - Neuropsyc hobiology. -1993. - Vol. 27(3). - P. 122-126.

Spina E., Perugi G. Antiepileptic drugs: indications other than epilepsy. - Epileptic Disord.- 2004. - Vol. 6. - P. 57-75.

Spina E., Santoro V., D’Arrigo C. Clinically Relevant Pharmacokinetic Drug Interactions with Second-Generation Antidepressants: an update. - Clin Ther. - 2008. - Vol. 30(7). - P. 1206-27.

Suppes T., Dennehy E.B., Hirschfeld R.M., Altshuler L.L., Bowden C.L., Calabrese J.R., Crismon M.L., Ketter T.A., Sachs G.S., Swann A.C. Texas Consensus Conference Panel on Medication Treatment of Bipolar Disorder. The Texas implementation of medication algorithms: update to the algorithms for treatment bipolar I disorder. - J. Clin. Psychiatry. - 2005. - Vol. 66(7). - P. 870-886.

Tellez-Zenteno J.F., Patten S.B., Jette N., Williams J., Wiebe S.: Psychiatric comorbidity in epilepsy: a population-based analysis. - Epilepsia. - 2007. - Vol.48. - P. 2336-2344.

Harris E.C. Barraclough B: Suicide as an outcome for mental disorders. A meta-analysis. - Br J Psychiatry. -1997. - Vol. 170. - P. 205-228.

Temkin O. The Falling Sickness: a History of Epilepsy from the Greeks to the beginnings of Modern Neurology. - 1971. - John Hopkins University Press, Baltimore. MD USA.

Trimble M.R., Krishnamoorthy E.S. The use of ECT in neuropsychiatric disorders. - 2005. - In: The ECT handbook (2nd edition). Scott AIF (Ed.). The Royal College of Psychiatrists, London, UK. - P. 47-56.

Vieweg V., Shutty M., Hundley P., Leadbetter R. Combined treatment with lithium and carbamazepine. - Am. J. Psychiatry. - 1991. - Vol. 148. - P. 398-399.

Wolf P. Manic episodes in epilepsy. - In: Advances in Epileptology: 13th Epilepsy International Symposium. Akimoto H, Kazamatsuri H, Seino M, Ward AA Jr (Eds). - 1982. - Raven Press, New York, USA. - P. 237-240.

Yilmaz Z., Ceschi A., Rauber-Luthy C.H., Sauer O., Stedtler U., Prasa D., Seidel C., Hackl E., Hoffmann-Walbeck P., Gerber-Zupan G., Bauer K., Kupfershmidt H., Kullak-Ublick G.-A., Wilks M. Escitalopram causes fewer seizures in human overdose than citalopram. - Clinical Toxicology. - 2010. - Vol. 48. - P. 207-212.

The authors declare that there are no conflicts of interest present.